---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-21-000025"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2021-12-15T23:59:59+00:00"
generated_at: "2026-06-28T00:46:24.484088+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Charles River Laboratories adopts proxy access bylaw amendment

## Summary
- Stockholders owning at least 3% of outstanding stock for 3+ years can nominate directors.
- Groups of up to 20 stockholders may aggregate ownership to meet the threshold.
- Nominees can constitute up to the greater of 2 directors or 20% of the board.
- Amendments effective December 13, 2021; includes conforming and routine updates.

## SEC filing metadata
- accession: 0001100682-21-000025
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2021-12-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068221000025/0001100682-21-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068221000025/crl-20211213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-21-000025
- JSON: https://secwatch.observer/filing/0001100682-21-000025.json
- Plain text: https://secwatch.observer/filing/0001100682-21-000025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.